Yung‐Heng Lee

423 total citations
19 papers, 203 citations indexed

About

Yung‐Heng Lee is a scholar working on Rheumatology, Surgery and Pharmacology. According to data from OpenAlex, Yung‐Heng Lee has authored 19 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 6 papers in Surgery and 5 papers in Pharmacology. Recurrent topics in Yung‐Heng Lee's work include Rheumatoid Arthritis Research and Therapies (7 papers), Spondyloarthritis Studies and Treatments (5 papers) and Osteoarthritis Treatment and Mechanisms (4 papers). Yung‐Heng Lee is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Spondyloarthritis Studies and Treatments (5 papers) and Osteoarthritis Treatment and Mechanisms (4 papers). Yung‐Heng Lee collaborates with scholars based in Taiwan, China and United States. Yung‐Heng Lee's co-authors include James Cheng‐Chung Wei, Wen‐Chen Tsai, Pei‐Tseng Kung, Yueh‐Hsin Wang, Chun‐Ting Li, Yen-Nien Chen, Chi‐Jen Chung, Chih‐Wei Wang, Chih‐Han Chang and Chih‐Hsien Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Environmental Research and Public Health.

In The Last Decade

Yung‐Heng Lee

17 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yung‐Heng Lee Taiwan 7 76 59 55 53 34 19 203
Tetiana Glushko United States 6 97 1.3× 92 1.6× 93 1.7× 52 1.0× 43 1.3× 13 295
Malte Schroeder Germany 11 159 2.1× 79 1.3× 25 0.5× 20 0.4× 21 0.6× 28 298
Megan Bowers United Kingdom 8 160 2.1× 58 1.0× 186 3.4× 46 0.9× 76 2.2× 21 386
Armando Conchiglia Italy 8 138 1.8× 64 1.1× 104 1.9× 35 0.7× 48 1.4× 10 284
Muriel Moris Belgium 6 58 0.8× 30 0.5× 86 1.6× 55 1.0× 21 0.6× 9 275
Michael P. Fice United States 9 201 2.6× 55 0.9× 44 0.8× 24 0.5× 10 0.3× 25 355
Masaru Kitajima Japan 10 252 3.3× 23 0.4× 31 0.6× 21 0.4× 28 0.8× 42 326
Patinharayil Gopinathan India 9 226 3.0× 22 0.4× 57 1.0× 28 0.5× 29 0.9× 18 301
Ken Saag United States 3 129 1.7× 25 0.4× 20 0.4× 88 1.7× 20 0.6× 4 313

Countries citing papers authored by Yung‐Heng Lee

Since Specialization
Citations

This map shows the geographic impact of Yung‐Heng Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yung‐Heng Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yung‐Heng Lee more than expected).

Fields of papers citing papers by Yung‐Heng Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yung‐Heng Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yung‐Heng Lee. The network helps show where Yung‐Heng Lee may publish in the future.

Co-authorship network of co-authors of Yung‐Heng Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Yung‐Heng Lee. A scholar is included among the top collaborators of Yung‐Heng Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yung‐Heng Lee. Yung‐Heng Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lee, Yung‐Heng, et al.. (2025). Fracture Risk Linked to Proton Pump Inhibitors Versus H2 Receptor Antagonists in Autoimmune Rheumatic and Gastrointestinal Disease Patients. International Journal of Rheumatic Diseases. 28(2). e70055–e70055. 1 indexed citations
2.
Lee, Yung‐Heng, et al.. (2025). Ankylosing Spondylitis and Cancer Risk. International Journal of Rheumatic Diseases. 28(1). e70085–e70085.
3.
Lee, Yung‐Heng, et al.. (2025). The Safety and Efficacy of JAK Inhibitors: Have We Found the Right Pathway?. International Journal of Rheumatic Diseases. 28(5). e70130–e70130.
4.
Huang, Kui-Chou, Chien-Chou Pan, Chung‐Yuh Tzeng, et al.. (2024). Factors influencing the decision to receive total knee replacement among patients with severe knee osteoarthritis under universal health insurance coverage. Scientific Reports. 14(1). 30028–30028. 2 indexed citations
5.
Lee, Yung‐Heng, et al.. (2023). Recent targets of osteoarthritis research. Best Practice & Research Clinical Rheumatology. 37(2). 101851–101851. 4 indexed citations
6.
Lee, Yung‐Heng, et al.. (2023). Association of Hallux Valgus with Degenerative Spinal Diseases: A Population-Based Cohort Study. International Journal of Environmental Research and Public Health. 20(2). 1152–1152. 1 indexed citations
7.
Lee, Yung‐Heng, et al.. (2022). No increased risk of alopecia in ankylosing spondylitis patients: A population‐based cohort study in Taiwan. International Journal of Rheumatic Diseases. 25(8). 937–944. 2 indexed citations
8.
Huang, Jinxian, Yung‐Heng Lee, & James Cheng‐Chung Wei. (2022). Benefits of tumor necrosis factor inhibitors for cardiovascular disease in ankylosing spondylitis. International Immunopharmacology. 112. 109207–109207. 4 indexed citations
9.
Lee, Yung‐Heng, et al.. (2022). Celecoxib and Etoricoxib may reduce risk of ischemic stroke in patients with rheumatoid arthritis: A nationwide retrospective cohort study. Frontiers in Neurology. 13. 1018521–1018521. 4 indexed citations
10.
Lee, Yung‐Heng, et al.. (2022). Effect of metabolic syndrome and obesity on the progression of knee osteoarthritis. International Journal of Rheumatic Diseases. 26(2). 391–392. 3 indexed citations
11.
Gau, Shuo‐Yan, Yung‐Heng Lee, Hsi‐Kai Tsou, et al.. (2021). Patients With Ankylosing Spondylitis Are Associated With High Risk of Fibromyalgia: A Nationwide Population-Based Cohort Study. Frontiers in Medicine. 8. 618594–618594. 10 indexed citations
13.
Chang, Yi-Jung, Yung‐Heng Lee, Pui‐Ying Leong, Yu‐Hsun Wang, & James Cheng‐Chung Wei. (2020). Impact of Rheumatoid Arthritis on Alopecia: A Nationwide Population-Based Cohort Study in Taiwan. Frontiers in Medicine. 7. 150–150. 11 indexed citations
14.
Lee, Yung‐Heng, et al.. (2020). Risk of Total Knee and Hip Arthroplasty in Patients With Rheumatoid Arthritis: A 12-Year Retrospective Cohort Study of 65,898 Patients. The Journal of Arthroplasty. 35(12). 3517–3523. 10 indexed citations
15.
Lee, Yung‐Heng, et al.. (2020). Patients With Rheumatoid Arthritis Increased Risk of Developing Osteoarthritis: A Nationwide Population-Based Cohort Study in Taiwan. Frontiers in Medicine. 7. 392–392. 19 indexed citations
16.
Huang, Jinxian, Yung‐Heng Lee, & James Cheng‐Chung Wei. (2020). Ixekizumab for the treatment of ankylosing spondylitis. Expert Review of Clinical Immunology. 16(8). 745–750. 11 indexed citations
17.
18.
Lee, Yung‐Heng, et al.. (2019). Effect of length of time from diagnosis to treatment on colorectal cancer survival: A population-based study. PLoS ONE. 14(1). e0210465–e0210465. 59 indexed citations
19.
Lee, Yung‐Heng, Chi‐Jen Chung, Chih‐Wei Wang, et al.. (2016). Computational comparison of three posterior lumbar interbody fusion techniques by using porous titanium interbody cages with 50% porosity. Computers in Biology and Medicine. 71. 35–45. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026